Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wedel

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Heart (British Cardiac Society)|October 6, 2007
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimenP Lindgren, M Buxton, T Kahan, et al.
Statistics in Medicine|April 1, 1985
On the use of the logistic model in prospective studiesM Halperin, R D Abbott, W C Blackwelder, et al.
American Journal of Epidemiology|June 1, 1985
Cessation of smoking after myocardial infarction in women. Effects on mortality and reinfarctionsS Johansson, R Bergstrand, K Pennert, et al.
European Heart Journal|April 1, 1986
The multifactor primary prevention trial in Göteborg, SwedenL Wilhelmsen, G Berglund, D Elmfeldt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1988
Serum lipids and apolipoprotein levels in women with acute myocardial infarctionS Johansson, G Bondjers, G Fager, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
British Heart Journal|May 1, 1984
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarctionJ Herlitz, A Hjalmarson, S Holmberg, et al.
European Journal of Haematology|November 10, 2000
Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992B Ridell, J Carneskog, H Wedel, et al.
Acta Medica Scandinavica|January 1, 1985
Tolerability to treatment with metoprolol in acute myocardial infarction in relation to ageJ Herlitz, A Hjalmarson, S Holmberg, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Heart (British Cardiac Society)|October 6, 2007
Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimenP Lindgren, M Buxton, T Kahan, et al.
Statistics in Medicine|April 1, 1985
On the use of the logistic model in prospective studiesM Halperin, R D Abbott, W C Blackwelder, et al.
American Journal of Epidemiology|June 1, 1985
Cessation of smoking after myocardial infarction in women. Effects on mortality and reinfarctionsS Johansson, R Bergstrand, K Pennert, et al.
European Heart Journal|April 1, 1986
The multifactor primary prevention trial in Göteborg, SwedenL Wilhelmsen, G Berglund, D Elmfeldt, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 1, 1996
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failureO Samuelsson, P O Attman, C Knight-Gibson, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1988
Serum lipids and apolipoprotein levels in women with acute myocardial infarctionS Johansson, G Bondjers, G Fager, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
British Heart Journal|May 1, 1984
Development of congestive heart failure after treatment with metoprolol in acute myocardial infarctionJ Herlitz, A Hjalmarson, S Holmberg, et al.
European Journal of Haematology|November 10, 2000
Incidence of chronic myeloproliferative disorders in the city of Göteborg, Sweden 1983-1992B Ridell, J Carneskog, H Wedel, et al.
Acta Medica Scandinavica|January 1, 1985
Tolerability to treatment with metoprolol in acute myocardial infarction in relation to ageJ Herlitz, A Hjalmarson, S Holmberg, et al.
Pageof 17